Default Category
-
Embrace (B): Opportunity Assessment
Mridula Anand; Anand Nandkumar; Charles DhanarajCase IVEY-9B13M005-EEntrepreneurship, StrategyAWARD WINNING CASE - Indian Management Issues and Opportunities Award, 2013 European Foundation for Management Development (EFMD) Case Writing Competition. Part B of a four-part series, which also includes 9B13M004, 9B13M006 and 9B13M007.Starting at €5.74
-
Embrace (C): Competing with Incumbents
Mridula Anand; Anand Nandkumar; Charles DhanarajCase IVEY-9B13M006-EEntrepreneurship, StrategyAWARD WINNING CASE - Indian Management Issues and Opportunities Award, 2013 European Foundation for Management Development (EFMD) Case Writing Competition. Part C of a four-part series, which also includes 9B13M004, 9B13M005 and 9B13M007.Starting at €5.74
-
Alibaba Group (Spanish version)
Wulf, Julie M.Case HBS-710S18StrategyDiscusses how Alibaba Group successfully managed new business ventures to become a leader in China's online marketplaces. Students follow Alibaba Group's transition from a startup to a multibusiness firm with over 15,000 employees in just over a decade. They analyze the evolving dynamics of internal competition and cooperation among Alibaba Group's subsidiaries. Students are also asked to address Alibaba Group's strategy, the role of its corporat...Starting at €8.20
-
Oral Insulin: Breakthrough Innovation at Biocon
Nita Sachan; Prasad Kaipa; Anand Nandkumar; Charles DhanarajCase IVEY-9B11M065-EEntrepreneurship, Service and Operations Management, StrategyThis case deals with the innovation challenges of a medium-sized firm (under $1 billion) in an emerging economy (India), particularly the challenges of product development and commercialization. The management has to decide how to proceed with a promising novel formula for oral insulin — promising both in terms of financial returns as well as social impact. The company has spent several years of research and development in getting the drug throug...Starting at €8.20
-
Centre for Cellular and Molecular Biology: The Commercialization Challenge
Nita Sachan; Prasad Vemuri; Anand Nandkumar; Charles DhanarajCase IVEY-9B11M064-ECorporate Governance, StrategyThis case deals with the commercialization challenges that a premier research institute in an emerging economy faces despite conducting cutting-edge research. The case is set in 2009 in Hyderabad, India, soon after the appointment of CCMB’s new director, Dr. Mohan Rao. Rao has to decide how to proceed with incentivizing the scientists to find potential applications for their research when most scientists are merely interested in doing basic resea...Starting at €8.20
-
Novartis in India: Innovation versus Affordability
Anand Nandkumar; Charles Dhanaraj; Mridula AnandCase IVEY-9B12M111-EStrategyThis case presents complex managerial challenges that stem from the institutional context in emerging markets, particularly in relation to the intellectual property regime and its impact on business strategy. The case centres around a multinational pharmaceutical firm, Novartis International AG (Novartis), that is waiting on a major court decision regarding patent policy as it pertains to one of the firm’s products. The case takes students throug...Starting at €8.20
-
Embrace (D): Building the Business Model
Mridula Anand; Anand Nandkumar; Charles DhanarajCase IVEY-9B13M007-EEntrepreneurship, StrategyAWARD WINNING CASE - Indian Management Issues and Opportunities Award, 2013 European Foundation for Management Development (EFMD) Case Writing Competition. Part D of a four-part series, which also includes 9B13M004, 9B13M005 and 9B13M006.Starting at €5.74
-
Alibaba's Taobao (A) & (B), Teaching Note
Oberholzer-Gee, Felix; Wulf, Julie M.Teaching Note HBS-712477-EStrategyTeaching Note for 709-456 and 709-457.Starting at €0.00
-
Alibaba's Taobao (A)
Oberholzer-Gee, Felix; Wulf, Julie M.Case HBS-709456-EStrategyExamines the decision of Alibaba Group to diversify from an international business-to-business (B2B) exchange (Alibaba.com) into a B2C and C2C exchange (Taobao.com) for Chinese retailers and consumers. In China, Taobao had managed to displace the once dominant eBay, the world's largest consumer marketplace. However, the company had little revenue because it offered services free of charge.Starting at €8.20
-
Alibaba's Taobao (B)
Oberholzer-Gee, Felix; Wulf, Julie M.Case HBS-709457-EStrategyStarting at €5.74